Riskpilot← Back to searchSign inGet full accessBrille Nord A/S
A/SActiveCVR 42003433Øster Snedevej 15ARetail sale of medical and orthopaedic goods · NACE 4774Est. 20214 employees
Revenue 2025
DKK 1,4M
+6% vs 2024
EBITDA margin
33.6%
-17% vs 2024
Equity ratio
81.2%
Financial strength
Net profit 2025
DKK 356K
-18% vs 2024
| Revenue | DKK 1,4M | +6% |
| EBITDA | DKK 479K | -17% |
| Net profit | DKK 356K | -18% |
| Total assets | DKK 1,4M | +7% |
| Equity | DKK 1,1M | +16% |
| Employees | 4 | — |
Legal name
Brille Nord A/S
CVR number
42003433
Legal form
Aktieselskab
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
8. januar 2021
Share capital
DKK 400.000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren, af direktøren sammen med et bestyrelsesmedlem, to bestyrelsesmedlemmer i
forening eller af den samlede bestyrelse.
Company purpose
Selskabets formål er detailhandel med briller og kontaktlinser samt andet hermed beslægtet virksomhed.
Address
Øster Snedevej 15A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 492 | 614 | 805 | 1.348 | 1.423 |
| Staff expenses | -427 | -490 | -536 | -774 | -945 |
| EBITDA | 65 | 124 | 269 | 574 | 479 |
| Depreciation & amort. | -10 | -10 | -10 | -10 | -10 |
| EBIT | 55 | 114 | 259 | 564 | 469 |
| Net financials | -2 | -2 | -0 | -2 | -9 |
| Profit before tax | 53 | 112 | 259 | 562 | 460 |
| Tax | 14 | 26 | 59 | 127 | 104 |
| Net profit | 39 | 86 | 201 | 435 | 356 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 596 | 672 | 966 | 1.278 | 1.369 |
| Equity | 439 | 526 | 701 | 956 | 1.113 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 155 | 143 | 261 | 318 | 254 |
| Total debt | 155 | 143 | 261 | 318 | 254 |
EBITDA margin
33.6%
This company
15.8%
Market median
+113% vs market
20212025
Equity ratio
81.2%
This company
38.2%
Market median
+113% vs market
20212025
Return on equity
32.0%
This company
18.4%
Market median
+74% vs market
20212025
Net profit margin
25.0%
This company
8.1%
Market median
+209% vs market
20212025
Asset turnover
1.04×
This company
1.12×
Market median
+7% vs market
20212025
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-08 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KK Management | Management | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2021 | |
| Company | 50–66.65% | 50–66.65% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
INVESTERINGSSELSKABET HL III ApS
Brille Nord A/S Board members of Brille Nord A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristina Kragh Laursen | Management | 0 companies |
| Mette Schjødt Laursen | Board of Directors | 0 companies |
| Thomas Nymark Laursen | Chairman | 0 companies |